Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity

Observational studies suggest outpatient metformin use is associated with reduced mortality from coronavirus disease‐2019 (COVID‐19). Metformin is known to decrease interleukin‐6 and tumor‐necrosis factor‐α, which appear to contribute to morbidity in COVID‐19. We sought to understand whether outpati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramante, Carolyn T., Buse, John, Tamaritz, Leonardo, Palacio, Ana, Cohen, Ken, Vojta, Deneen, Liebovitz, David, Mitchell, Nia, Nicklas, Jacinda, Lingvay, Ildiko, Clark, Jeanne M., Aronne, Louis J., Anderson, Erik, Usher, Michael, Demmer, Ryan, Melton, Genevieve B., Ingraham, Nicholas, Tignanelli, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013587/
https://www.ncbi.nlm.nih.gov/pubmed/33580540
http://dx.doi.org/10.1002/jmv.26873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013587/
https://www.ncbi.nlm.nih.gov/pubmed/33580540
http://dx.doi.org/10.1002/jmv.26873

Ejemplares similares